Thank you for joining us today.
Expect a brief satisfaction survey via email immediately following the presentation. Your feedback is appreciated as it helps improve programming for the future.
The program will review
background information followed by the most up-to-date data supporting the
efficacy and safety of OFEV. The presentation is sponsored by Boehringer
Ingelheim Pharmaceuticals, Inc.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.